Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LMP02
- Development stage
- Preclinical
- Lead developer
- Torrent Pharmaceuticals
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes, Peptides
- Administration
- Oral
01
Overview
LMP02 is a proprietary oral delivery platform developed by Curatio Therapeutics, currently in the preclinical stage of development. The technology utilizes precision cellular engineering to facilitate the transport of large-molecule biologics—including mRNA, DNA, proteins, and biosimilars—across the gastrointestinal (GI) tract. By overcoming the biological barriers that typically prevent the oral administration of biologics, LMP02 aims to replace traditional injections and infusions with oral formulations. Preliminary preclinical results have demonstrated the platform's potential to deliver a diverse range of therapeutic modalities effectively.
Beyond the preview
Go deeper on LMP02.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LMP02.